Shionogi & Co., Ltd. (4507.T)
JPY 2178.5
(0.51%)
JPY 2178.5
(0.51%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 186.7 Billion JPY | -21.58% |
| 2022 | 176.41 Billion JPY | 68.69% |
| 2021 | 143.42 Billion JPY | -9.62% |
| 2020 | 158.67 Billion JPY | -9.42% |
| 2019 | 174.47 Billion JPY | -6.9% |
| 2018 | 194.69 Billion JPY | 18.12% |
| 2017 | 134.22 Billion JPY | 13.11% |
| 2016 | 124.51 Billion JPY | 20.13% |
| 2015 | 107.27 Billion JPY | 22.79% |
| 2014 | 66.01 Billion JPY | 16.98% |
| 2013 | 79.18 Billion JPY | 7.84% |
| 2012 | 74.54 Billion JPY | 12.79% |
| 2011 | 62.53 Billion JPY | -2.73% |
| 2010 | 56.96 Billion JPY | -6.71% |
| 2009 | 81.99 Billion JPY | 57.13% |
| 2008 | 44.95 Billion JPY | -8.31% |
| 2007 | 50.71 Billion JPY | 29.49% |
| 2006 | 40.61 Billion JPY | -6.02% |
| 2005 | 47.57 Billion JPY | 7.58% |
| 2004 | 41.5 Billion JPY | 25.61% |
| 2003 | 31.22 Billion JPY | 1.88% |
| 2002 | 30.64 Billion JPY | 17.88% |
| 2001 | 25.99 Billion JPY | -21.63% |
| 2000 | 33.17 Billion JPY | -13.15% |
| 1999 | 38.21 Billion JPY | 21.42% |
| 1998 | 31.45 Billion JPY | 6.1% |
| 1997 | 29.64 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 65.45 Billion JPY | 98.16% |
| 2024 Q1 | 33.02 Billion JPY | -4.33% |
| 2023 Q1 | 61.04 Billion JPY | 107.39% |
| 2023 Q3 | 56.56 Billion JPY | -15.06% |
| 2023 Q2 | 66.59 Billion JPY | 9.1% |
| 2023 FY | - JPY | -21.58% |
| 2023 Q4 | 28.84 Billion JPY | -49.01% |
| 2022 Q2 | 32.82 Billion JPY | -26.47% |
| 2022 FY | - JPY | 68.69% |
| 2022 Q4 | 29.43 Billion JPY | -78.34% |
| 2022 Q1 | 44.63 Billion JPY | -20.29% |
| 2022 Q3 | 135.86 Billion JPY | 313.95% |
| 2021 Q4 | 55.99 Billion JPY | 95.65% |
| 2021 Q3 | 28.61 Billion JPY | -10.79% |
| 2021 Q2 | 32.07 Billion JPY | 19.84% |
| 2021 FY | - JPY | -9.62% |
| 2021 Q1 | 26.76 Billion JPY | -9.76% |
| 2020 FY | - JPY | -9.42% |
| 2020 Q1 | 34.14 Billion JPY | -24.55% |
| 2020 Q2 | 41.22 Billion JPY | 20.75% |
| 2020 Q3 | 53.7 Billion JPY | 30.28% |
| 2020 Q4 | 29.66 Billion JPY | -44.77% |
| 2019 Q1 | 35.86 Billion JPY | -31.64% |
| 2019 Q2 | 41.18 Billion JPY | 14.85% |
| 2019 Q3 | 55 Billion JPY | 33.56% |
| 2019 FY | - JPY | -6.9% |
| 2019 Q4 | 45.24 Billion JPY | -17.75% |
| 2018 Q2 | 32.78 Billion JPY | -13.79% |
| 2018 Q4 | 52.45 Billion JPY | 14.61% |
| 2018 FY | - JPY | 18.12% |
| 2018 Q1 | 38.03 Billion JPY | 9.92% |
| 2018 Q3 | 45.77 Billion JPY | 39.61% |
| 2017 Q3 | 39.96 Billion JPY | -10.32% |
| 2017 Q2 | 44.56 Billion JPY | 109.92% |
| 2017 Q1 | 21.23 Billion JPY | -35.15% |
| 2017 FY | - JPY | 13.11% |
| 2017 Q4 | 34.59 Billion JPY | -13.43% |
| 2016 FY | - JPY | 20.13% |
| 2016 Q2 | 25.51 Billion JPY | 52.51% |
| 2016 Q1 | 16.73 Billion JPY | -51.8% |
| 2016 Q3 | 48.87 Billion JPY | 91.54% |
| 2016 Q4 | 32.73 Billion JPY | -33.02% |
| 2015 FY | - JPY | 22.79% |
| 2015 Q3 | 31.8 Billion JPY | 58.21% |
| 2015 Q2 | 20.1 Billion JPY | 37.17% |
| 2015 Q1 | 14.65 Billion JPY | -45.88% |
| 2015 Q4 | 34.71 Billion JPY | 9.16% |
| 2014 Q3 | 20.83 Billion JPY | 15.04% |
| 2014 FY | - JPY | 16.98% |
| 2014 Q2 | 18.11 Billion JPY | 31.93% |
| 2014 Q1 | 13.72 Billion JPY | 9.26% |
| 2014 Q4 | 27.07 Billion JPY | 29.96% |
| 2013 Q4 | 12.56 Billion JPY | -48.73% |
| 2013 FY | - JPY | 7.84% |
| 2013 Q1 | 13.12 Billion JPY | -23.39% |
| 2013 Q2 | 15.82 Billion JPY | 20.63% |
| 2013 Q3 | 24.51 Billion JPY | 54.86% |
| 2012 Q4 | 17.12 Billion JPY | -3.63% |
| 2012 FY | - JPY | 12.79% |
| 2012 Q2 | 13.32 Billion JPY | 7.64% |
| 2012 Q1 | 12.37 Billion JPY | 4.43% |
| 2012 Q3 | 17.77 Billion JPY | 33.39% |
| 2011 Q2 | 7.06 Billion JPY | -41.28% |
| 2011 Q4 | 11.85 Billion JPY | -28.06% |
| 2011 Q1 | 12.03 Billion JPY | -26.98% |
| 2011 Q3 | 16.47 Billion JPY | 133.22% |
| 2011 FY | - JPY | -2.73% |
| 2010 Q2 | 15.92 Billion JPY | 4.53% |
| 2010 Q1 | 15.23 Billion JPY | -34.59% |
| 2010 Q4 | 16.47 Billion JPY | -22.88% |
| 2010 Q3 | 21.36 Billion JPY | 34.14% |
| 2010 FY | - JPY | -6.71% |
| 2009 Q4 | 23.29 Billion JPY | 2.08% |
| 2009 Q2 | 16.43 Billion JPY | 43.82% |
| 2009 Q1 | 11.42 Billion JPY | -22.11% |
| 2009 FY | - JPY | 57.13% |
| 2009 Q3 | 22.82 Billion JPY | 38.9% |
| 2008 Q3 | 7.85 Billion JPY | -26.01% |
| 2008 FY | - JPY | -8.31% |
| 2008 Q4 | 14.66 Billion JPY | 86.72% |
| 2008 Q2 | 10.61 Billion JPY | 0.0% |
| 2007 FY | - JPY | 29.49% |
| 2006 FY | - JPY | -6.02% |
| 2005 FY | - JPY | 7.58% |
| 2004 FY | - JPY | 25.61% |
| 2003 FY | - JPY | 1.88% |
| 2002 FY | - JPY | 17.88% |
| 2001 FY | - JPY | -21.63% |
| 2000 FY | - JPY | -13.15% |
| 1999 FY | - JPY | 21.42% |
| 1998 FY | - JPY | 6.1% |
| 1997 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.02 Billion JPY | -3000.847% |
| Takeda Pharmaceutical Company Limited | 874.6 Billion JPY | 78.653% |
| Sumitomo Pharma Co., Ltd. | -281.07 Billion JPY | 166.425% |
| Wakamoto Pharmaceutical Co.,Ltd. | 570.97 Million JPY | -32598.976% |
| Nippon Shinyaku Co., Ltd. | 36.29 Billion JPY | -414.472% |
| Kaken Pharmaceutical Co., Ltd. | 12.26 Billion JPY | -1421.986% |
| Eisai Co., Ltd. | 103.1 Billion JPY | -81.078% |
| Morishita Jintan Co., Ltd. | 1.29 Billion JPY | -14339.443% |
| Hisamitsu Pharmaceutical Co., Inc. | 18.34 Billion JPY | -918.004% |
| Mochida Pharmaceutical Co., Ltd. | 8.97 Billion JPY | -1980.709% |
| Fuso Pharmaceutical Industries,Ltd. | 3.67 Billion JPY | -4987.248% |
| Nippon Chemiphar Co., Ltd. | 1.4 Billion JPY | -13207.341% |
| Tsumura & Co. | 30.77 Billion JPY | -506.727% |
| Kissei Pharmaceutical Co., Ltd. | 18.72 Billion JPY | -897.34% |
| Torii Pharmaceutical Co., Ltd. | 5.27 Billion JPY | -3442.06% |
| Towa Pharmaceutical Co., Ltd. | 35.53 Billion JPY | -425.388% |
| Fuji Pharma Co., Ltd. | 6.88 Billion JPY | -2612.903% |
| Zeria Pharmaceutical Co., Ltd. | 17.52 Billion JPY | -965.551% |
| KYORIN Holdings, Inc. | 10.29 Billion JPY | -1713.345% |
| Taiko Pharmaceutical Co.,Ltd. | -3.75 Billion JPY | 5078.72% |
| Daito Pharmaceutical Co.,Ltd. | 7.55 Billion JPY | -2371.892% |
| SymBio Pharmaceuticals Limited | -714 Million JPY | 26248.739% |
| MedRx Co., Ltd | -884.51 Million JPY | 21207.815% |
| Mizuho Medy Co.,Ltd. | 5.53 Billion JPY | -3272.331% |
| Solasia Pharma K.K. | -635 Million JPY | 29501.89% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 7964.703% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.16 Billion JPY | -1937.564% |
| Sawai Group Holdings Co., Ltd. | 36.87 Billion JPY | -406.338% |
| Cyfuse Biomedical K.K. | -538.28 Million JPY | 34784.342% |
| Toho Holdings Co., Ltd. | 25.84 Billion JPY | -622.391% |
| Koa Shoji Holdings Co.,Ltd. | 5.1 Billion JPY | -3559.646% |